Bioqual, Inc. engages in the provision and development of medical research and consulting services to commercial clients and government laboratories. The company is headquartered in Rockville, Maryland. The company also performs in vitro contract research services. The company is involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. Its services also encompass sample processing and custom assays for serology, cell-mediated immunity, viral loads, and bacterial enumeration. Its model services also include syngeneic mouse tumor allograft and select human cell line derived xenograft (CDX) models, and it offers GLP-compliant preclinical testing services in various small animal models. The company provides its services to the federal government, universities and the life science and pharmaceutical industries.
Bioqual Inc hisse başına yıllık % {var1} temettüye sahiptir ve % {var2} oranında bir getiri sunmaktadır. Temettü yıllık ödenmektedir ve son temettü hariç tarihi Oct 7, 2024 tarihindedir.
Dividend Yield
Yıllık Dividende
Özsermaye Tarihi
2.5967%
$0.50
Oct 7, 2024
Ödeme Sıklığı
Ödeme Oranı
Yıllık
254.487%
Dividend History
Özsermaye Tarihi
Nakit Tutarı
Kayıt Tarihi
Ödeme Tarihi
Oct 7, 2024
$0.50
Oct 7, 2024
Oct 28, 2024
Oct 5, 2023
$0.50
Oct 6, 2023
Oct 27, 2023
Oct 5, 2022
$1.00
Oct 6, 2022
Oct 27, 2022
Sep 25, 2020
$1.10
Sep 28, 2020
Oct 21, 2020
Sep 24, 2019
$0.70
Sep 25, 2019
Oct 16, 2019
Dividend Grafikleri
BIOQ Kâr Payları
BIOQ Dividend Growth (Yıllık Üstünlük)
Follow-Up Questions
Bioqual Inc'in şu anki temettü ödemesi ve yıllık temettüsü nedir?